Bone changes in myelofibrosis with myeloid metaplasia: A histomorphometric and microcomputed tomographic study

European Journal of Haematology

Volumn 78, Issue 6, 2007, Pages 500-509

  Schmidt, Aline ^a   Blanchet, Odile ^b   Dib, Mamoun ^a   Baslé, Michel F ^c   Ifrah, Norbert ^a   Chappard, Daniel ^c  

^a Service d'Hématologie UPRES EA 3863   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

^c INSERM   (France)

Author keywords

Bone histomorphometry; microCT; Myelofibrosis; Myelofibrosis with myeloid metaplasia; Myeloid metaplasia; Osteosclerosis

Indexed keywords

ADULT; AGED; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE REMODELING; CELL ACTIVITY; CELL COUNT; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILIAC CREST; LIFESPAN; MALE; MEGAKARYOCYTE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MYELOFIBROSIS; MYELOID METAPLASIA; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOID; PRIORITY JOURNAL; TRABECULAR BONE;

BONE AND BONES; HUMANS; METAPLASIA; MYELOFIBROSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248547646     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00852.x     Document Type: Article

References (50)

1. Barosi G, Ambrosetti A, Finelli C, et al. The Italian consensus conference on diagnostic criteria for myelofibrosis with myeloid metaplasia. Br J Haematol 1999 104 : 730 7.
2. Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader BE. Wintrobe's Clinical Hematology, 11th edn. Philadelphia : Lippincott Williams & Wilkins, 2003.
3. Steensma DP, Hanson CA, Letendre L, Tefferi A. Myelodysplasia with fibrosis: a distinct entity? Leuk Res 2001 25 : 829 38.
4. Le Bousse-Kerdiles MC, Martyre MC. Myelofibrosis: pathogenesis of myelofibrosis with myeloid metaplasia. French INSERM Research Network on Myelofibrosis with Myeloid Metaplasia. Springer Semin Immunopathol 1999 21 : 491 508.
5. Ward HP, Block MH. The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine (Baltimore) 1971 50 : 357 420.
6. Pugsley MK, Tabrizchi R. The vascular system: an overview of structure and function. J Pharmacol Toxicol Meth 2000 44 : 333 40.
7. Compston JE. Bone marrow and bone: a functional unit. J Endocrinol 2002 173 : 387 94.
8. Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barillé S. Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment. Blood 2001 98 : 3527 33.
9. Pearse R, Sordillo E, Yaccoby S, Wong B, Liau D, Colman N, Michaeli J, Epstein J, Choi Y. Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis of trigger bone destruction and promote tumor progression. Proc Natl Acad Sci U S A 2001 98 : 11581 6.
10. Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M. Macrophage inflammatory protein 1-α is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000 15 : 671 5.
11. Mohla S, Weilbacher KN, Cher ML, Oyajobi BO, Van Poznak C, Clohisy DR. Third North American symposium on skeletal complications of malignancy. Cancer 2003 97 : 719 25.
12. Deftos LJ. Prostate carcinoma: production of bioactive factors. Cancer 2000 88 : 3002 8.
13. Calvi LM, Adams GB, Weibrecht KW, et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003 425 : 841 6.
14. Olmsted-Davis EA, Gugala Z, Camargo F, et al. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A 2003 100 : 15877 82.
15. Chappard D, Blouin S, Libouban H, Baslé MF, Audran M. Microcomputed tomography for the study of hard tissues and bone biomaterials. Microsc Anal 2005 19 : 17 19.
16. Krause JR. Myeloproliferative disorders. In : Krause JR, ed. Bone Marrow Biopsy. New York : Churchill Livingstone, 1981 : 96 99.
17. Michiels JJ, Thiele J. Clinical and pathological criteria for the diagnosis of essential thrombocytohemia, polycythemia vera, and idiopathic myelofibrosis(agnogenic myeloid metaplasia). Int J Hematol 2002 76 : 133 45.
18. Dupriez B, Demory JL, Lai JL, Fenaux P, Bauters F. Prognostic classification of myelofibrosis with myeloid metaplasia. Br J Haematol 1989 73 : 136 7.
19. Bataille R, Chappard D, Baslé M. Quantifiable excess of bone resorption in monoclonal gammopathy is an early symptom of malignancy: a prospective study of 87 bone biopsies. Blood 1996 87 : 4762 9.
20. Rossi JF, Chappard D, Marcelli C, Laplante J, Commes T, Baldet P, Janbon C, Jourdan J, Alexandre C, Bataille R. Microosteoclast resorption as a characteristic feature of B-cell malignancies other than multiple myeloma. Br J Haematol 1990 76 : 469 75.
21. Coindre JM, Reiffers J, Goussot JF, De Mascarel A, Broustet A. Histomorphometric analysis of sclerotic bone from idiopathic myeloid metaplasia (nine cases). J Pathol 1984 144 : 163 9.
22. Chappard D, Alexandre C, Riffat G. Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem 1983 27 : 75 85.
23. Parfitt AM, Drezner MK, Glorieux FG, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987 2 : 595 610.
24. Chappard D. Osteoclast count on human bone biopsies: Why and How? In : Takahashi HE ed. Bone Morphometry. Niigata : NishimuraSmithGordon, 1990 : 248 55.
25. Courpron P, Meunier P, Edouard C, Bernard J, Bringuier JP, Vignon G. Données histologiques quantitatives sur le vieillissement osseux humain. Rev Rhum Mal Osteoartic 1973 40 : 469 83.
26. Meunier P, Courpron P. Iliac trabecular bone volume in 236 controls - representativeness of iliac samples. In : Jaworski ZFG, Klosevych S eds. Proceeding of the First Worhshop On Bone Histomorphometry. Ottawa : University of Ottawa, 1976 : 100 5.
27. Chappard D, Legrand E, Pascaretti C, Baslé MF, Audran M. Comparison of eight histomorphometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Techn 1999 45 : 303 12.
28. Chappard D, Alexandre C, Riffat G. Spatial distribution of trabeculae in iliac bone from 145 osteoporotic females. Acta Anat 1988 132 : 137 42.
29. Chappard D, Legrand E, Basle MF, Fromont P, Racineux JL, Rebel A, Audran M. Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study. J Bone Miner Res 1996 11 : 676 85.
30. Palle S, Chappard D, Vico L, Riffat G, Alexandre C. Evaluation of the osteoclastic population in iliac crest biopsies from 36 normal subjects: a histoenzymologic and histomorphometric study. J Bone Miner Res 1989 4 : 501 6.
31. Hildebrand T, Ruegsegger P. A new method for the model-independent assessment of thickness in three-dimensional images. J Microsc 1997 185 : 67 75.
32. Darby AJ, Meunier PJ. Mean wall thickness and formation periods of trabecular bone packets in idiopathic osteoporosis. Calcif Tissue Int 1981 33 : 199 204.
33. Kragstrup J, Gundersen HJ, Melsen F, Mosekilde L. Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Relat Res 1982 4 : 113 9.
34. Thiele J, Hoeppner B, Wienhold S, Schneider S, Fischer R, Zankovich R. Osteoclasts and bone remodeling in chronic myeloproliferative disorders. A histochemica and morphometric study on trephine biopsies in 165 patients. Path ResPract 1989 184 : 591 9.
35. Poulsen LW, Melsen F, Bendix K. A histomorphometric study of haematological disorders with respect to marrow fibrosis and osteosclerosis. APMIS 1998 106 : 495 9.
36. Chappard D, Ifrah N, François S, Boasson M, Baslé MF. Increased lamellar number per bone structure unit in myelodysplastic disorders with osteosclerosis (abstract). Bone 1996 17 : 560.
37. Chappard D, Retailleau-Gaborit N, Legrand E, Baslé MF, Audran M. Comparison insight bone measurements by histomorphometry and micro-computed tomography. J Bone Miner Res 2005 20 : 1177 84.
38. Wang JC, Lang HD, Lichter S, Weinstein M, Benn P. Cytogenetic studies of bone marrow fibroblasts cultured from patients with myelofibrosis and myeloid metaplasia. Br J Haematol 1992 80 : 184 8.
39. Fazzi R, Pacini S, Testi R, Azzara A, Galimberti S, Testi C, Trombi L, Metelli MR, Petrini M. Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis. Br J Haematol 2003 121 : 76 85.
40. Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC. Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone 2004 35 : 1316 22.
41. Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F. Prominent role of TGF-beta 1 in thrombopoietin-induced myelofibrosis in mice. Blood 2002 100 : 3495 503.
42. Martyré MC, Magdelenat H, Bryckaert MC, Laine-Bidron C, Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia. Br J Haematol 1991 77 : 80 86.
43. Martyré MC, Le Bousse-Kerdiles MC, Romquin N, Chevillard S, Praloran V, Demory JL, Dupriez B. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. Br J Haematol 1997 97 : 441 8.
44. Karst M, Gorny G, Galvin RJ, Oursler MJ. Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation. J Cell Physiol 2004 200 : 99 106.
45. Quinn JM, Itoh K, Udagawa N, et al. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. J Bone Miner Res 2001 16 : 1787 94.
46. Bord S, Frith E, Ireland DC, Scott MA, Craig JI, Compston JE. Megakaryocytes modulate osteoblast synthesis of type-l collagen, osteoprotegerin, and RANKL. Bone 2005 36 : 812 9.
47. Elliot MA, Yoon SY, Kao P, Li CY, Tefferi A. Simultaneous measurement of serum thrombopoietin and expression of megakaryocyte c-Mpl with clinical and laboratory correlates for myelofibrosis with myeloid metaplasia. Eur J Haematol 2002 68 : 175 9.
48. Rameshwar P, Narayanan R, Qian J, Denny TN, Colon C, Gascon P. NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J Immunol 2000 165 : 2271 7.
49. Chenu C, Delmas PD. Platelets contribute to circulating levels of bone sialoprotein in human. J Bone Miner Res 1992 7 : 47 54.
50. Boucharaba A, Serre CM, Gres S, Saulnier-Blache JS, Bordet JC, Guglielmi J, Clezardin P, Peyruchaud O. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. J Clin Invest 2004 114 : 1714 25.